Introduction: Tuberculosis (TB) is a transmissible disease caused by Mycobacterium tuberculosis, which continues to be a major public health issue worldwide. The situation has become more alarming with the increasing cases of multidrug-resistant (MDR) strains, which makes treatment difficult. Nitrofurans, a class of heterocyclic compounds known for their antimicrobial potential, have gained renewed attention as scaffolds for anti-TB drug design. This study aimed to investigate the structural features governing the antitubercular activity of 5-nitrofuranyl derivatives using 2D-QSAR modeling and molecular docking analysis and to identify new compounds that inhibit the biosynthesis of the Mycobacterium tuberculosis cell wall. Method: Twenty-eight 5-nitrofuranyl derivatives were studied by means of 2D-QSAR analysis employing descriptors from the Dragon software suite within the framework of CP–MLR methodology. Statistically significant models were selected based on r², Q² (LOO and L5O), and test set predictivity. Molecular docking was performed using AutoDock Vina against Galactofuranosyltransferase 2 (GlfT2), a validated target involved in the cell wall biosynthesis of M. tuberculosis. Result: Robust QSAR models were obtained with up to R² = 0.912 and Q²LOO = 0.839. Key descriptors influencing activity included topological descriptors (IC1, JGI2, JGI5), mass-weighted Burden eigenvalues (BELm2, BELm6), molecular weight (MW), and selected atom-centered fragments such as C-006 and C-031. Docking studies revealed that several compounds (notably 27, 25, and 3) exhibited high binding affinity to GlfT2 (−9 to −6.7 kcal/mol), correlating well with QSAR predictions. Discussion: The obtained QSAR parameters suggested the importance of molecular topology, electronic features, and particular structural fragments in modulating antitubercular activity. Molecular docking to the GlfT2 protein showed that the binding affinity of compounds 27, 25, and 3 was found to be more favorable for their binding in the active site of the enzyme. Moreover, the results from the ADME study demonstrated that compound 3 acquired the best pharmacokinetic properties compared to the other molecules. Conclusion: This integrated QSAR and molecular modeling study highlights the structural determinants of 5- nitrofuranyl-based antituberculosis agents. Compounds with favorable descriptor profiles and strong GlfT2 binding affinity represent promising leads for further development. This approach demonstrates the effectiveness of combining ligand- and structure-based strategies for rational antitubercular drug design.